77 related articles for article (PubMed ID: 11101342)
41. Impact of tether length on bone mineral affinity of protein-bisphosphonate conjugates.
Gittens SA; Kitov PI; Matyas JR; Löbenberg R; Uludağ H
Pharm Res; 2004 Apr; 21(4):608-16. PubMed ID: 15139517
[TBL] [Abstract][Full Text] [Related]
42. Imparting bone affinity to glycoproteins through the conjugation of bisphosphonates.
Gittens SA; Matyas JR; Zernicke RF; Uludağ H
Pharm Res; 2003 Jul; 20(7):978-87. PubMed ID: 12880282
[TBL] [Abstract][Full Text] [Related]
43. [Retention of 99mTc-diphosphonate in the bones and soft tissues of rats: distribution, time factors, the effect of age].
Kapitola J; Kobos L; Jahoda I; Vilimovská D
Sb Lek; 1987; 89(2-3):60-6. PubMed ID: 3589471
[No Abstract] [Full Text] [Related]
44. [Changes of the content of hydroxyapatite and collagen in bone tissue of ovariectomized rats].
Pang W; Kang L; Fu YL; Yu XD; Wang QY
Zhongguo Gu Shang; 2011 May; 24(5):424-5. PubMed ID: 21688546
[No Abstract] [Full Text] [Related]
45. Iodine-131-labeled diphosphonates for the palliative treatment of bone metastases: I. Organ distribution and kinetics of I-131 BDP3 in rats.
Eisenhut M
J Nucl Med; 1984 Dec; 25(12):1356-61. PubMed ID: 6209369
[TBL] [Abstract][Full Text] [Related]
46. Determination of the rat in vivo pharmacokinetic profile of a bone-targeting dual-action pro-drug for treatment of osteoporosis.
Chen G; Arns S; Young RN
Bioconjug Chem; 2015 Jun; 26(6):1095-103. PubMed ID: 25945831
[TBL] [Abstract][Full Text] [Related]
47. The comparative retention of bone-seeking radionuclides in the skeletons of rats.
Taylor DM
Health Phys; 1983 Sep; 45(3):768-72. PubMed ID: 6885483
[No Abstract] [Full Text] [Related]
48. Retention and distribution of injected Californium-252 in the rat.
Mewhinney JA; Ziemer PL; Landolt RR
Health Phys; 1971 Dec; 21(6):857-60. PubMed ID: 5212286
[No Abstract] [Full Text] [Related]
49. [The diphosphonates].
Dolev E
Harefuah; 1984 Feb; 106(3):137-40. PubMed ID: 6724386
[No Abstract] [Full Text] [Related]
50. Biomaterial-assisted local and systemic delivery of bioactive agents for bone repair.
Zeng Y; Hoque J; Varghese S
Acta Biomater; 2019 Jul; 93():152-168. PubMed ID: 30711659
[TBL] [Abstract][Full Text] [Related]
51. Multivalent Presentation of Peptide Targeting Groups Alters Polymer Biodistribution to Target Tissues.
Newman MR; Russell SG; Schmitt CS; Marozas IA; Sheu TJ; Puzas JE; Benoit DSW
Biomacromolecules; 2018 Jan; 19(1):71-84. PubMed ID: 29227674
[TBL] [Abstract][Full Text] [Related]
52. Characterization of synthesized NANO-encapsulated drug for bone loss on hind limb suspension rat model by NMR and micro-CT.
Ni Q; Dixon H; Gutierrez G; Bi L; Qin YX
Adv Biosci Bioeng (N Y); 2013 Jun; 1(1):1-7. PubMed ID: 28042594
[TBL] [Abstract][Full Text] [Related]
53. Enhancement of the Regenerative Potential of Anorganic Bovine Bone Graft Utilizing a Polyglutamate-Modified BMP2 Peptide with Improved Binding to Calcium-Containing Materials.
Bain JL; Bonvallet PP; Abou-Arraj RV; Schupbach P; Reddy MS; Bellis SL
Tissue Eng Part A; 2015 Sep; 21(17-18):2426-36. PubMed ID: 26176902
[TBL] [Abstract][Full Text] [Related]
54. Comparing variable-length polyglutamate domains to anchor an osteoinductive collagen-mimetic peptide to diverse bone grafting materials.
Bain JL; Culpepper BK; Reddy MS; Bellis SL
Int J Oral Maxillofac Implants; 2014; 29(6):1437-45. PubMed ID: 25397807
[TBL] [Abstract][Full Text] [Related]
55. Biomaterials that regulate growth factor activity via bioinspired interactions.
Hudalla GA; Murphy WL
Adv Funct Mater; 2011 May; 21(10):1754-1768. PubMed ID: 21921999
[TBL] [Abstract][Full Text] [Related]
56. Non-invasive monitoring of BMP-2 retention and bone formation in composites for bone tissue engineering using SPECT/CT and scintillation probes.
Kempen DH; Yaszemski MJ; Heijink A; Hefferan TE; Creemers LB; Britson J; Maran A; Classic KL; Dhert WJ; Lu L
J Control Release; 2009 Mar; 134(3):169-76. PubMed ID: 19105972
[TBL] [Abstract][Full Text] [Related]
57. Selective drug delivery to bone using acidic oligopeptides.
Ishizaki J; Waki Y; Takahashi-Nishioka T; Yokogawa K; Miyamoto K
J Bone Miner Metab; 2009; 27(1):1-8. PubMed ID: 19018455
[No Abstract] [Full Text] [Related]
58. Non-invasive screening method for simultaneous evaluation of in vivo growth factor release profiles from multiple ectopic bone tissue engineering implants.
Kempen DH; Lu L; Classic KL; Hefferan TE; Creemers LB; Maran A; Dhert WJ; Yaszemski MJ
J Control Release; 2008 Aug; 130(1):15-21. PubMed ID: 18554743
[TBL] [Abstract][Full Text] [Related]
59. Ligand-modified aminobisphosphonate for linking proteins to hydroxyapatite and bone surface.
Ehrick RS; Capaccio M; Puleo DA; Bachas LG
Bioconjug Chem; 2008 Jan; 19(1):315-21. PubMed ID: 18001076
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
